Obstetrics & Gynecology Doctors in Long Beach, NY Accepting Medicare

3 Obstetrics & Gynecology doctors found. Showing 1 - 3

Dr. Manuel A Veloso Jr., MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 303 E Park Ave, Long Beach, NY 11561 Phone: 516-431-2828    Fax: 516-431-3747

Dr. Neeraj Goswamy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 111 Mitchell Ave, Long Beach, NY 11561 Phone: 516-432-2368    Fax: 516-526-9030

Patrick Edwin Mcmanus, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 303 E Park Ave, Long Beach, NY 11561 Phone: 516-431-1919    Fax: 516-431-8642

News Archive

Over 96% of SIDS cases due to known risk factors

Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.

Interactive Autism Network to join National Patient-Centered Clinical Research Network

The Interactive Autism Network, a project of the Kennedy Krieger Institute supported by the Simons Foundation, was approved today for a three-year $1.6 million funding award by the Patient-Centered Outcomes Research Institute to be part of PCORnet, the National Patient-Centered Clinical Research Network.

New FDA approved drug to treat infants with respiratory distress syndrome

Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome.

Precision Therapeutics to present clinical data of ChemoFx chemoresponse assay at WAGO meeting

Precision Therapeutics, Inc., a life science company that develops personalized medicine products for individualizing cancer care, today announced that a clinical study which demonstrates the feasibility of the ChemoFx chemoresponse assay to identify patients unlikely to respond to first-line therapy has been accepted for presentation at the 2013 Annual Meeting of the Western Association of Gynecologic Oncologists.

Read more Medical News

› Verified 3 days ago